Promoter region methylation does not account for the frequent loss of expression of the Fas gene in colorectal carcinoma

被引:0
|
作者
Butler, LM
Dobrovic, A
Bianco, T
Cowled, PA [1 ]
机构
[1] Univ Adelaide, Dept Surg, Adelaide, SA 5005, Australia
[2] Univ Adelaide, Dept Med, Adelaide, SA 5005, Australia
[3] Queen Elizabeth Hosp, Dept Haematol Oncol, Woodville, SA 5011, Australia
关键词
CpG island; methylation; gene silencing; apoptosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression of the apoptosis-promoting Fas gene is frequently reduced or lost during the development of colorectal carcinoma. However, loss of heterozygosity at the Fas locus or Fas gene rearrangements do not account for the loss of expression of Fas, raising the possibility that methylation of the Fas promoter may inhibit gene expression in colorectal carcinomas. We have examined the Fas promoter region CpG island for evidence of hypermethylation in colorectal tumours. Forty-seven specimens of colorectal adenoma and carcinoma, as well as six samples of normal colonic mucosa, were examined by Southern blotting for methylation at Hpall and Cfol sites in this region. No methylation was detected in any of the specimens, suggesting that hypermethylation is not primarily responsible for the loss of expression of the Fas gene during colorectal tumorigenesis. (C) 2000 Cancer Research Campaign.
引用
收藏
页码:131 / 135
页数:5
相关论文
共 50 条
  • [31] Promoter methylation of SFRP1 is frequent in hepatocellular carcinoma
    Lin, Ya-Wen
    Shih, Yu-Lueng
    Hsieh, Chung-Bao
    Lai, Hung-Cheng
    Chu, Tang-Yuan
    CANCER RESEARCH, 2006, 66 (08)
  • [32] Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma
    S-W Park
    J Ludes-Meyers
    D B Zimonjic
    M E Durkin
    N C Popescu
    C M Aldaz
    British Journal of Cancer, 2004, 91 : 753 - 759
  • [33] Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma
    Park, SW
    Ludes-Meyers, J
    Zimonjic, DB
    Durkin, ME
    Popescu, NC
    Aldaz, CM
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 753 - 759
  • [34] The Study of DNA Methylation of bax Gene Promoter in Breast and Colorectal Carcinoma Cell Lines
    Alipour, Mohsen
    Zargar, Seyed Jalal
    Safarian, Shahrokh
    Fouladdel, Shamileh
    Azizi, Ebrahim
    Jafargholizadeh, Naser
    IRANIAN JOURNAL OF CANCER PREVENTION, 2013, 6 (02) : 59 - 64
  • [35] A20 gene promoter methylation confers resistance to colorectal carcinoma cell lines
    Siraj, Abdul K.
    Al-Rasheed, Maha
    Bavi, Prashant
    Hussain, Azhar
    Al-Sanea, Nasser
    Al-Dayel, Fouad
    Uddin, Shahab
    Al-Kuraya, Khawla S.
    CANCER RESEARCH, 2012, 72
  • [36] Restoring FAS expression by reversing FAS promoter methylation: A novel approach to CTCL therapy
    Wu, J.
    Wood, G. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S29 - S29
  • [37] Promoter methylation and downregulated expression of the TBX15 gene in ovarian carcinoma
    Gozzi, Gaia
    Chelbi, Sonia T.
    Manni, Paola
    Alberti, Loredana
    Fonda, Sergio
    Saponaro, Sara
    Fabbiani, Luca
    Rivasi, Francesco
    Benhattar, Jean
    Losi, Lorena
    ONCOLOGY LETTERS, 2016, 12 (04) : 2811 - 2819
  • [38] Promoter Methylation and mRNA Expression of Response Gene to Complement 32 in Breast Carcinoma
    Eskandari-Nasab, Ebrahim
    Hashemi, Mohammad
    Rafighdoost, Firoozeh
    JOURNAL OF CANCER EPIDEMIOLOGY, 2016, 2016
  • [39] OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma
    Ye, Feng
    Zhang, Song-Fa
    Xie, Xing
    Lu, Wei-Guo
    CANCER INVESTIGATION, 2008, 26 (06) : 569 - 574
  • [40] Expression of CBY and methylation of CBY at promoter region in human laryngeal squamous cell carcinoma
    Ren, Gang
    Zhao, De-an
    Xu, Jue
    Li, Bo-an
    TUMORI JOURNAL, 2015, 101 (02): : 215 - 222